Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2004 3
2006 2
2007 2
2008 2
2009 2
2010 4
2012 2
2013 5
2014 1
2016 1
2017 2
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Rationale and design of the CV-PREVITAL study: an Italian multiple cohort randomised controlled trial investigating innovative digital strategies in primary cardiovascular prevention.
Baldassarre D, Iacoviello L, Baetta R, Roncaglioni MC, Condorelli G, Remuzzi G, Gensini G, Frati L, Ricciardi W, Conaldi PG, Uccelli A, Blandini F, Bosari S, Scambia G, Fini M, Di Malta A, Amato M, Veglia F, Bonomi A, Klersy C, Colazzo F, Pengo M, Gorini F, Auteri L, Ferrante G, Baviera M, Ambrosio G, Catapano A, Gialluisi A, Malavazos AE, Castelvecchio S, Corsi-Romanelli MM, Cardani R, La Rovere MT, Agnese V, Pane B, Prati D, Spinardi L, Liuzzo G, Arbustini E, Volterrani M, Visconti M, Werba JP, Genovese S, Bilo G, Invitti C, Di Blasio A, Lombardi C, Faini A, Rosa D, Ojeda-Fernández L, Foresta A, De Curtis A, Di Castelnuovo A, Scalvini S, Pierobon A, Gorini A, Valenti L, Luzi L, Racca A, Bandi M, Tremoli E, Menicanti L, Parati G, Pompilio G; CV-PREVITAL Study Group. Baldassarre D, et al. BMJ Open. 2023 Jul 14;13(7):e072040. doi: 10.1136/bmjopen-2023-072040. BMJ Open. 2023. PMID: 37451717 Free PMC article. Clinical Trial.
Stem-cell therapy for amyotrophic lateral sclerosis.
Silani V, Cova L, Corbo M, Ciammola A, Polli E. Silani V, et al. Among authors: cova l. Lancet. 2004 Jul 10-16;364(9429):200-2. doi: 10.1016/S0140-6736(04)16634-8. Lancet. 2004. PMID: 15246734 Review.
Stem cells in the treatment of amyotrophic lateral sclerosis (ALS).
Silani V, Fogh I, Ratti A, Sassone J, Ciammola A, Cova L. Silani V, et al. Among authors: cova l. Amyotroph Lateral Scler Other Motor Neuron Disord. 2002 Dec;3(4):173-81. doi: 10.1080/146608202760839001. Amyotroph Lateral Scler Other Motor Neuron Disord. 2002. PMID: 12710505 Review.
Preface.
Eridani S, Cova L. Eridani S, et al. Among authors: cova l. Cytotechnology. 2003 Mar;41(2-3):51-2. doi: 10.1023/A:1024848509173. Cytotechnology. 2003. PMID: 19002941 Free PMC article. No abstract available.
NMR Metabolomics for Stem Cell type discrimination.
Castiglione F, Ferro M, Mavroudakis E, Pellitteri R, Bossolasco P, Zaccheo D, Morbidelli M, Silani V, Mele A, Moscatelli D, Cova L. Castiglione F, et al. Among authors: cova l. Sci Rep. 2017 Nov 17;7(1):15808. doi: 10.1038/s41598-017-16043-8. Sci Rep. 2017. PMID: 29150616 Free PMC article.
Exosome microRNAs in Amyotrophic Lateral Sclerosis: A Pilot Study.
Pregnolato F, Cova L, Doretti A, Bardelli D, Silani V, Bossolasco P. Pregnolato F, et al. Among authors: cova l. Biomolecules. 2021 Aug 16;11(8):1220. doi: 10.3390/biom11081220. Biomolecules. 2021. PMID: 34439885 Free PMC article.
Human neural stem cells express extra-neural markers.
Parati EA, Bez A, Ponti D, de Grazia U, Corsini E, Cova L, Sala S, Colombo A, Alessandri G, Pagano SF. Parati EA, et al. Among authors: cova l. Brain Res. 2002 Jan 25;925(2):213-21. doi: 10.1016/s0006-8993(01)03291-7. Brain Res. 2002. PMID: 11792370
29 results